Sustainability | December 12, 2025
Dr. Reddy's Laboratories announces SBTi targets
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
Zyrifa is indicated for patients with bone metastases stemming from a wide range of solid tumors
The patented product, developed by Venus Medicine Research Centre (VMRC) for the treatment of multidrug-resistant (MDR) infections, was sold to Cipla in 2019
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Here's a new ray of hope for new hope for patients suffering from Meniere’s disease (MD) and sensorineural hearing loss
The agreement allows Biocon Biologics to commercialize both its Denosumab biosimilars (Vevzuo and Evfraxy) in Europe starting December 2, 2025
FDA's withholding of the PRV was contrary to law because no drug product containing phenobarbital sodium was 'previously approved'
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
Subscribe To Our Newsletter & Stay Updated
